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Clinical PerspectiveWhat Is New?Immunoglobulins, the major effector molecules of B cells, promoted chronic inflammation both in mouse model of abdominal aortic aneurysm (AAA) and in human AAA tissue in culture.Syk, a tyrosine kinase that is essential both for B‐cell activation and for the function of immunoglobulins, was activated in mouse AAA tissue.Genetic deletion of mature B cells or pharmacological inhibition of Syk ameliorated AAA development in mice.What Are the Clinical Implications?Activation of B cells, pathogenic effect of immunoglobulins, and activation of Syk represent potential therapeutic targets for AAA.Monitoring their activities may provide a clue for the disease activity of AAA.

 {#jah33018-sec-0008}

Abdominal aortic aneurysm (AAA) is a common aortic disease in older individuals (over 70 years old).[1](#jah33018-bib-0001){ref-type="ref"} AAA is caused by the local weakening of aortic walls. Although patients with AAA seldom show clinical symptoms or signs for years, the AAA diameter slowly expands and leads to the catastrophic events of aortic rupture and sudden death. Currently, no therapy is available to halt the expansion of AAA. Thus, the only therapeutic option is watchful observation and, before rupture, replacing the diseased aorta with an artificial graft, either through open surgery or endovascular aneurysm repair (EVAR) with a self‐expandable stent‐graft.[2](#jah33018-bib-0002){ref-type="ref"} Although EVAR is less invasive than open repair, long‐term aortic complications or stent‐graft--associated complications occur more commonly in EVAR, possibly due to the fragility of the aortic wall.[3](#jah33018-bib-0003){ref-type="ref"}, [4](#jah33018-bib-0004){ref-type="ref"} To develop strategies for slowing AAA expansion and to provide better clinical outcomes with EVAR, it is essential to understand the pathogenesis of AAA.[5](#jah33018-bib-0005){ref-type="ref"}

Decades of research have revealed the molecular pathogenesis of AAA.[6](#jah33018-bib-0006){ref-type="ref"}, [7](#jah33018-bib-0007){ref-type="ref"}, [8](#jah33018-bib-0008){ref-type="ref"} We know that chronic inflammation plays a central role in promoting tissue destruction and in suppressing tissue repair. Suppressing inflammatory signaling was proven to be effective in preventing the progression and promoting the healing of AAA in animal models.[6](#jah33018-bib-0006){ref-type="ref"}, [8](#jah33018-bib-0008){ref-type="ref"}, [9](#jah33018-bib-0009){ref-type="ref"} Human AAA tissue is characterized by an early infiltration of inflammatory cells, including neutrophils, macrophages, T cells, and B cells, which occurs before detectable extracellular matrix (ECM) destruction and aortic diameter expansion.[1](#jah33018-bib-0001){ref-type="ref"} Although both AAA and aortic occlusive disease show prominent cellular infiltration, AAA is more enriched in B cells and immunoglobulins, which suggested that these factors might be involved in AAA pathogenesis.[10](#jah33018-bib-0010){ref-type="ref"}, [11](#jah33018-bib-0011){ref-type="ref"}, [12](#jah33018-bib-0012){ref-type="ref"} Indeed, a series of studies have demonstrated that B cells promoted AAA by producing immunoglobulins against fibrinogen, which then activated the complement pathway, in an elastase‐induced mouse model.[13](#jah33018-bib-0013){ref-type="ref"}, [14](#jah33018-bib-0014){ref-type="ref"} Consistently, it has been reported that the depletion of B cells with an anti‐CD20 antibody protected the aorta from AAA development in the elastase‐induced model and in an angiotensin II--induced model in *Apoe*‐deficient mice.[15](#jah33018-bib-0015){ref-type="ref"} However, the involvement of B cells in AAA pathogenesis is controversial. Another study reported that, with the same elastase‐induced AAA model, B cell--deficient mice developed AAA equivalent to wild‐type (WT) mice, and B2‐cell administration ameliorated AAA development.[16](#jah33018-bib-0016){ref-type="ref"} Those findings indicated that further evaluations should be performed to determine the significance of B cells in AAA pathogenesis, preferably in a different model of AAA, because currently used animal models of AAA are significantly different from each other, and no single model recapitulates all aspects of human AAA.[6](#jah33018-bib-0006){ref-type="ref"} Moreover, evaluating the role of B cells and immunoglobulins in human AAA tissue is preferable because no single animal model has recapitulated all aspects of human AAA.[6](#jah33018-bib-0006){ref-type="ref"} In addition, if B cells are involved in AAA pathogenesis, therapeutic targets that can modulate B‐cell function should be explored.

The goal of the current study was to evaluate the role of B cells/immunoglobulins in a widely used murine AAA model, which is induced with a periaortic application of CaCl~2~,[17](#jah33018-bib-0017){ref-type="ref"} and in human AAA tissue cultures. We also explored the therapeutic potential of inhibiting Syk, a tyrosine kinase that plays a central role in B‐cell activation and in immunoglobulin effector functions.[18](#jah33018-bib-0018){ref-type="ref"}, [19](#jah33018-bib-0019){ref-type="ref"}, [20](#jah33018-bib-0020){ref-type="ref"}, [21](#jah33018-bib-0021){ref-type="ref"}

Methods {#jah33018-sec-0009}
=======

The data, analytic methods, and study materials will be available to other researchers for purposes of reproducing the results or replicating the procedure, as long as the situation allows. The analytic methods and data are described in this article except for the transcriptome data set, which has been deposited to the Gene Expression Omnibus of the National Center for Biotechnology Information (accession \#[GSE109640](GSE109640)).[22](#jah33018-bib-0022){ref-type="ref"} The study materials are commercially available except for human AAA tissue samples, which will not be publicly available.

Animal Experiments {#jah33018-sec-0010}
------------------

All animal experimental protocols were approved by the Animal Experiments Review Boards of Kurume University. To create a mouse model of AAA, we placed a periaortic application of 0.5 mol/L CaCl~2~ onto the infrarenal aorta for 20 minutes. This treatment caused chronic local inflammation, as described previously.[17](#jah33018-bib-0017){ref-type="ref"} We previously confirmed that the local inflammation was not elicited by a sham operation in which physiological saline had been used instead of CaCl~2~.[23](#jah33018-bib-0023){ref-type="ref"} Mice were killed with a pentobarbital overdose, and blood and tissue samples were collected at 2 time points: at 7 days after the CaCl~2~ treatment and at 42 days after the CaCl~2~ treatment. Aortic tissue was excised either immediately, for protein and mRNA expression analyses, or after perfusion and fixation with 4% paraformaldehyde in phosphate‐buffered saline at physiological pressure, for histological analysis. Aortic enlargement was defined as a diameter equal to or exceeding 1.5‐fold greater than the control aorta diameter. For protein and mRNA expression analyses, aortic tissue was rapidly frozen in liquid nitrogen and stored at −80°C until sample extraction.

To assess the role of B cells in AAA pathogenesis, we used muMT mice, which are deficient in membrane‐bound IgM, on a background of C57BL/6J (Jackson Laboratory \#002288, Bar Harbor, ME). WT mice with the same genetic background served as controls. To evaluate the role of Syk in AAA pathogenesis, we used R788 (fostamatinib, MedChemeExpress, Monmouth Junction, NJ, USA), an orally available prodrug of the selective Syk inhibitor, R406. R788 was given ad libitum for 7 days before the CaCl~2~ treatment and afterwards, during the observational period. The concentration of R788 was 3 mg/mL in drinking water,[24](#jah33018-bib-0024){ref-type="ref"} with 0.1% carboxymethyl cellulose, 0.1% methylparaben, 0.02% propylparaben, and 1% sucrose. The control group received drinking water with 0.1% carboxymethyl cellulose, 0.1% methylparaben, 0.02% propylparaben, and 1% sucrose, without R788 (vehicle).

Human AAA Tissue {#jah33018-sec-0011}
----------------

All protocols that involved human specimens were approved by the Institutional Review Board at Kurume University Hospital, and all samples were obtained with informed consent from the patients. Human AAA tissue was obtained from patients during open surgery performed to repair AAA. Tissues were acquired from the anterior wall of the aneurysm, at the junction of a section with a normal diameter on 1 side and the dilated lesion on the other side. For histological analyses, AAA tissues were fixed in paraformaldehyde, paraffin embedded, and sliced into tissue sections 5 μm thick. For ex vivo cultures, we obtained fresh AAA samples from 2 patients, acquired during surgery as stated above, that were cleaned of thrombi and loose connective tissue. The aortic tissue was cut horizontally into 3 parts. Each part of the aortic wall was minced into pieces ≈2×2 mm, which maintained the full thickness of the aortic wall. Minced tissues were transferred to 12‐well plates with serum‐free DMEM (Invitrogen, Carlsbad, CA). Into each well we placed an equal number of pieces from all 3 parts of the AAA sample to minimize the effect of AAA tissue heterogeneity. At 24 hours after starting the culture, culture media were exchanged with fresh DMEM, and samples were incubated for 48 hours (the first 48 hours) to obtain conditioned media for measuring basal secretions of interleukin‐6 (IL‐6) and matrix metalloproteinase‐9 (MMP9). Then, culture media were exchanged with fresh DMEM, with or without 0.5 mg/mL human polyclonal IgG (Jackson ImmunoResearch, West Grove, PA; \#767‐71594), and cultures were incubated for another 48 hours (the second 48 hours) to obtain conditioned media after stimulation. Secreted IL‐6 and MMP9 were measured with an IL‐6 ELISA kit (R&D Systems, Minneapolis, MN; \#S6050) and gelatin zymography (ThermoFisher Scientific, Waltham, MA, USA; \#EC61755BOX), respectively. To adjust for tissue heterogeneity, all measured values were normalized to the basal secretion of a given molecule by dividing the measurement of the second 48 hours by the measurement of the first 48 hours from the same well. IL‐6 and MMP9 levels were evaluated as the fold change in normalized values relative to the normalized levels observed in unstimulated cultures, (designated as 1).

Expression Analysis {#jah33018-sec-0012}
-------------------

For protein expression analysis, aortic samples were pulverized with an SK mill (TOKKEN, Kashiwa, Japan), and proteins were extracted with RIPA buffer. The protein concentrations were determined by bicinchoninic acid assay (Thermo Fisher Scientific, Waltham, MA, USA) to adjust the protein loading on a NuPAGE system (Invitrogen, Carlsbad, CA). After resolving the proteins on the NuPAGE system, we performed immunoblotting with antibodies specific for Stat3 (Cell Signaling Technology, Danvers, MA; \#4904), phospho‐Stat3 (Tyr705, Cell Signaling Technology; \#9145), Jnk (Abcam, Cambridge, UK; \#ab112501), phospho‐Jnk (Thr183/Tyr185, Cell Signaling Technology; \#4671), Syk (Cell Signaling Technology; \#2712), phospho‐Syk (Tyr323, Cell Signaling Technology; \#2715), and lysyl oxidase (Abcam; \#ab31238). MMP9 expression was evaluated with gelatin zymography (ThermoFisher Scientific, Waltham, MA, USA; \#EC61755BOX). Expression levels of α‐tubulin were determined using a specific antibody (Abcam; \#ab40742) and used as an internal control to normalize the protein expressions. For mRNA expression analyses, we used aortic tissue from the same part of the aorta that was used in the protein expression analysis. We homogenized the tissues in TRIzol (Invitrogen) and isolated total RNA with RNeasy (Qiagen, Hilden, Germany). We performed transcriptome analyses with the SurePrint G3 Mouse Gene Expression 8x60K Microarray Kit (Agilent Technologies, Santa Clara, CA).

Histological Analysis {#jah33018-sec-0013}
---------------------

We stained paraffin‐embedded sections of aortic tissue with elastica van Gieson or hematoxylin and eosin. We performed immunohistochemical staining of mouse aortic tissue with antibodies specific for phospho‐Syk (Tyr323, Cell Signaling Technology; \#2715), B cells (B220, BD \#553086), and macrophages (Iba‐1, Millipore, Billerica, MA; \#MABN92). Deposition of immunoglobulins was detected by fluorescently labeled antibodies for mouse IgM (Abcam; \#ab150121) and IgG (Abcam; \#ab150117). We performed immunohistochemical staining of human AAA tissue with antibodies specific for B cells (CD19, Dako, Agilent Technologies; \#M729629), smooth muscle cells (smooth muscle α‐actin, Sigma‐Aldrich, St. Louis, MO; \#A5228), T cells (CD3, Abcam; \#ab16669), neutrophils (neutrophil elastase, Dako, Agilent Technologies; \#M075201), and macrophages (CD68, Dako, Agilent Technologies; \#M0876).

Statistical Analysis {#jah33018-sec-0014}
--------------------

Quantitative data are presented by box‐and‐whisker plots to show medians and interquartile ranges. Statistical analyses were performed with GraphPad PRISM 5 (GraphPad Software, San Diego, CA). When the data passed the D\'Agostino and Pearson normality test and Bartlett test for equal variances, we performed 1‐way ANOVAs to compare 3 or more groups, followed by Bonferroni multiple comparison test. For nonnormal data distributions, we performed the Kruskal‐Wallis test, followed by a Dunn multiple comparison test. Statistical significance was indicated by a *P*\<0.05.

Results {#jah33018-sec-0015}
=======

Presence of B Cells in AAA Tissue {#jah33018-sec-0016}
---------------------------------

We examined the presence of B cells and other inflammatory cells in AAA tissue samples obtained from patients who underwent open surgery to repair AAA (Figure [1](#jah33018-fig-0001){ref-type="fig"}A). Immunostaining with antibodies specific for different cell types, including B cells, indicated that B cells formed clusters with other inflammatory cells, including T cells and macrophages, which surrounded small vessels.[10](#jah33018-bib-0010){ref-type="ref"}, [11](#jah33018-bib-0011){ref-type="ref"} We next examined whether B cells were present in mouse aorta (Figure [1](#jah33018-fig-0001){ref-type="fig"}B). In the control, untreated mouse aorta, we found no B cells. We used a well‐established method to create a mouse model of AAA with a periaortic application of 0.5 mol/L CaCl~2~ for 20 minutes.[17](#jah33018-bib-0017){ref-type="ref"} This procedure caused inflammation, followed by chronic inflammation and destructive changes in the treated aortic walls. At 6 weeks after CaCl~2~ challenge, AAA had developed. When aortic tissues from these AAA mice were examined with immunostaining after the CaCl~2~ challenge, we observed a few B cells that had infiltrated the adventitia and had formed small clusters (Figure [1](#jah33018-fig-0001){ref-type="fig"}B). During the 6‐week time course of AAA development, B cells were observed throughout the study period, at 3, 7, 21, and 42 days after a CaCl~2~ challenge. The number of infiltrating B cells did not significantly change during this time course. We examined the presence of immunoglobulins, the main effector molecules of B cells, in the aortic walls during the development of AAA (Figure [1](#jah33018-fig-0001){ref-type="fig"}C). Depositions of IgM and IgG were barely detectable by Western blot before CaCl~2~ challenge but were readily detected in AAA tissue throughout the 6‐week observation period, and they apparently peaked at 1 week after the CaCl~2~ challenge. On the other hand, IgA and IgE were undetectable in our hands.

![Histology of human and mouse AAA. A, Representative photomicrographs of human AAA tissues. Sections were stained with elastica van Gieson (EVG), with hematoxylin and eosin (H&E), and with antibodies specific for B cells (CD19), smooth muscle cells (αSMA), T cells (CD3), neutrophils (Elastase), and macrophages (CD68). Black arrowheads in each panel indicate positive staining of the corresponding antigen. White arrowheads indicate small blood vessels. The section marked with black rectangle corners on the low‐magnification image (top left) is enlarged in the adjacent image. Scale bars: 100 μm. B, Mouse AAA model was created by treating with a periaortic application of 0.5 mol/L CaCl~2~. Upper, Representative aortic sections, histologically stained with EVG and H&E, are shown before (Pre) and 6 weeks after CaCl~2~ treatment (Ca). Lower, B‐cell infiltration is indicated with B220 immunostaining of aortic tissue 6 weeks after CaCl~2~ treatment. Black rectangle indicates the area enlarged in the inset. Scale bars: 50 μm. All images are shown with the luminal side up and adventitial side down. C, Immunoblotting (top) and quantification (bottom) of IgM and IgG in mouse aorta before and after CaCl~2~ treatment. Observation numbers are shown in parentheses at the bottom of the box‐and‐whisker plots. AAA indicates abdominal aortic aneurysm.](JAH3-7-e007750-g001){#jah33018-fig-0001}

We also performed immunostaining of IgM and IgG in aortic sections before and 1 week after a CaCl~2~ challenge (Figure [2](#jah33018-fig-0002){ref-type="fig"}). In aortic tissue without CaCl~2~ challenge, IgM and IgG were barely detectable. After CaCl~2~ challenge, IgM was detected in intima and adventitia, whereas IgG was diffusely stained in the adventitia of the aortic wall (Figure [2](#jah33018-fig-0002){ref-type="fig"}B). Immunofluorescence staining of B cells showed that part of IgM staining was in close proximity of B220‐positive B cells (Figure [2](#jah33018-fig-0002){ref-type="fig"}C). On the other hand, IgG was overlapping with most of the cells in the adventitia. These results indicated that inflammation of AAA tissue was accompanied by B‐cell infiltration in both human and mouse. The development of AAA in mice was also accompanied by the deposition of IgM and IgG.

![Deposition of immunoglobulins in mouse AAA. A, Tissue sections are shown for mouse aorta without (Pre) and with (Day 7) CaCl~2~ challenge by hematoxylin and eosin staining (H&E). Bar 200 μm. B, Deposition of IgM or IgG was detected by immunofluorescence staining (green color) and shown with nuclear staining (DAPI, blue color). Bar 200 μm. C, Deposition of IgM or IgG is visualized by immunofluorescence staining (green color in the rightmost panels) with B‐cell marker B220 staining (arrowheads, red color in the rightmost panels) in aortic tissue 7 days after CaCl~2~ challenge. Bar 50 μm. AAA indicates abdominal aortic aneurysm; DAPI, 4′,6‐Diamidino‐2‐Phenylindole, Dihydrochloride.](JAH3-7-e007750-g002){#jah33018-fig-0002}

Because it is well established that Syk, a hematopoietic lineage‐specific tyrosine kinase, is involved in the inflammatory response including B‐cell activation and effector function of immunoglobulins downstream of Fc receptors,[18](#jah33018-bib-0018){ref-type="ref"} we examined the activation status of Syk in the aorta by immunofluorescence staining of activated (phosphorylated) Syk (pSyk) before and after CaCl~2~ challenge (Figure [3](#jah33018-fig-0003){ref-type="fig"}). Before CaCl~2~ challenge, pSyk was barely detectable but was readily detectable mainly in adventitia 1 week after CaCl~2~ challenge (Figure [3](#jah33018-fig-0003){ref-type="fig"}A). To localize pSyk in specific cell types, we stained the AAA tissue for B220, a B‐cell marker (Figure [3](#jah33018-fig-0003){ref-type="fig"}B), and Iba‐1, a macrophage marker (Figure [3](#jah33018-fig-0003){ref-type="fig"}C). Although B220‐positive B cells were positive for pSyk, most of the pSyk‐positive cells were non‐B cells. Iba‐1‐positive macrophages were abundantly detected in the adventitia of AAA tissue, many of which were positive for pSyk. Collectively, the deposition of IgG on most of the adventitial cells and Syk activation in the infiltrating cells suggested that they may participate in AAA pathogenesis.

![Activation of Syk in mouse AAA. A, Representative images are shown for immunofluorescence staining for pSyk (green color) without (Pre) and with (Day 7) CaCl~2~ challenge. Bar 200 μm. B, Localization of B cells (B220, arrowheads, red color in the rightmost panel) is shown with pSyk (green color in the rightmost panel) in aortic tissue 7 days after CaCl~2~ challenge. Bar 50 μm. **C,** Localization of macrophages (Iba‐1, arrowheads, red color in the rightmost panel) is shown with pSyk (green color in the rightmost panel) in aortic tissue 7 days after CaCl~2~ challenge. Bar 50 μm. AAA indicates abdominal aortic aneurysm; pSyk, phosphorylated Syk.](JAH3-7-e007750-g003){#jah33018-fig-0003}

Involvement of B Cells in AAA Pathogenesis {#jah33018-sec-0017}
------------------------------------------

We examined the involvement of B cells in AAA pathogenesis using B cell--deficient muMT mice, which had undergone gene targeting to delete the heavy chain of IgM.[25](#jah33018-bib-0025){ref-type="ref"} IgM serves as a B‐cell receptor required for early B‐cell development. Thus, in muMT mice, B‐cell development is arrested, and the mice are deficient in mature B cells. When we treated muMT mice with CaCl~2~ to induce AAA, the AAA lesions were significantly smaller than those observed in WT (Figure [4](#jah33018-fig-0004){ref-type="fig"}A). This result indicated that B cells were required for the full development of AAA.

![AAA model in B cell‐deficient muMT mice. AAA mouse models were induced with a periaortic CaCl~2~ treatment. A Upper, Representative images of abdominal aortas before (Pre) and 6 weeks after CaCl~2~ treatment (Ca) in wild‐type (WT) and B cell--deficient (muMT) mice. White scale bar 2 mm. Lower, Quantitative analysis of the maximal diameters of abdominal aortas. Observation numbers are shown in parentheses at the bottom of the box‐and‐whisker plot. B, Upper, Protein expression levels were examined on immunoblots for the indicated proteins and with gelatin zymography for MMP9. Representative image shows aortic samples acquired before (Pre) and 7 days after CaCl~2~ treatment (Ca) from WT and muMT mice. Sham samples were treated with vehicle only. Lower, White and gray columns indicate WT and muMT mice, respectively. Observation numbers in each experimental group are shown in parentheses at the bottom of the box‐and‐whisker plots. Values indicate fold expression levels relative to expression in WT Pre samples. \**P*\<0.05, \*\**P*\<0.01, \*\*\**P*\<0.001. AAA indicates abdominal aortic aneurysm; MMP9, matrix metalloproteinase; WT, wild type.](JAH3-7-e007750-g004){#jah33018-fig-0004}

Next, we examined the expression levels of key molecules in AAA pathogenesis (Figure [4](#jah33018-fig-0004){ref-type="fig"}B). The small AAA lesions in muMT mice were associated with less significant activations of Jnk, Stat3, and Syk than those observed in WT AAA. Consistent with that finding, compared to WT AAA tissues, muMT AAA tissues showed less significant expression of MMP9, an ECM protease that is regulated by Jnk in AAA,[26](#jah33018-bib-0026){ref-type="ref"} and a more significant increase in the expression of lysyl oxidase (Lox), an ECM‐synthesizing enzyme that can ameliorate AAA development.[26](#jah33018-bib-0026){ref-type="ref"} The observed changes in the protein expressions were specific to CaCl~2~ challenge because they were not observed in sham‐operated mice, confirming the results of our previous article that saline treatment did not induce strong inflammation or AAA formation.[23](#jah33018-bib-0023){ref-type="ref"} These results indicated that a B‐cell deficiency resulted in the suppression of inflammatory signaling pathways including Syk and impeded development of AAA, possibly by suppressing ECM destruction and enhancing ECM synthesis.

Role of B Cells in Gene Expression During AAA Development {#jah33018-sec-0018}
---------------------------------------------------------

We performed a transcriptome analysis in mouse tissues extracted before and 7 days after CaCl~2~ challenge to gain insight into B‐cell involvement in AAA pathogenesis. Among the 55 681 probes on the DNA microarray, at 7 days after CaCl~2~ challenge, 3750 probes showed a significant increase (*P*\<0.05, fold change ≥2), and 3457 probes showed a significant decrease (*P*\<0.05, fold change ≤0.5) in expression in WT aortas (Table [1](#jah33018-tbl-0001){ref-type="table-wrap"}). At 7 days after CaCl~2~ challenge, muMT aortas showed higher expression in 299 probes and lower expression in 1244 probes compared to WT aortas at the corresponding time points. Among the probes with elevated expression in muMT aortas after CaCl~2~ challenge, 180 (60.2%) showed suppressed expression in WT aortas after CaCl~2~ challenge. Among the 1244 probes with suppressed expression in muMT aortas after CaCl~2~ challenge, 839 probes (67.4%) showed increased expression in WT aortas after CaCl~2~ challenge. These results indicated that a major effect of B‐cell deletion was to suppress the effects of CaCl~2~ challenge. Among the CaCl~2~ challenge‐induced and ‐suppressed probes in WT AAA aortas, 22.4% and 5.2%, respectively, were ameliorated by B‐cell deletion.

###### 

Changes in Gene Expression in a Mouse Model of AAA

  Number of Genes   muMT Day 7/WT Day 7                      
  ----------------- --------------------- ------ ---- ------ ------
  WT day7/WT pre    Up                    3750   1    839    2910
  Down              3457                  180    12   3265   
  No change         118                   393                

The number of genes that showed significant expression changes are shown for WT mice before (pre) and after CaCl~2~ treatment (day 7). The number of genes that showed significant expression changes after CaCl~2~ treatment are shown for muMT mice relative to WT mice. AAA indicates abdominal aortic aneurysm; WT, wild type.

We analyzed the functional annotations of the genes that were induced by CaCl~2~ challenge in WT tissues and suppressed by CaCl~2~ challenge in muMT tissues. Functional annotations were retrieved from DAVID (the Database for Annotation, Visualization, and Integrated Discovery).[27](#jah33018-bib-0027){ref-type="ref"} The gene ontology terms in DAVID revealed functional annotations that clustered with "immune response" and "defense response" (Table [2](#jah33018-tbl-0002){ref-type="table-wrap"}). We also performed a DAVID analysis of genes that were suppressed by CaCl~2~ challenge in WT tissues and restored by CaCl~2~ challenge in muMT tissues. The gene ontology terms revealed functional annotations that clustered with "myofibril," "muscle system process," and "muscle structure development" (Table [3](#jah33018-tbl-0003){ref-type="table-wrap"}). These results suggested that, in the mouse AAA model, immune and inflammatory responses were induced, and muscle components, probably representing aortic wall smooth muscle cells, were suppressed. These findings underscored the importance of B cells in AAA pathogenesis.

###### 

Functional Annotation Clusters of CaCl~2~‐Induced Genes With an Influence of B‐Cell Deletion

  Annotation Cluster 1   Enrichment Score: 33.77128000272969
  ---------------------- -----------------------------------------------------------
  GOTERM_BP_FAT          GO:0006955---immune response
  GOTERM_BP_FAT          GO:0045321---leukocyte activation
  GOTERM_BP_FAT          GO:0006952---defense response
  GOTERM_BP_FAT          GO:0002682---regulation of immune system process
  GOTERM_BP_FAT          GO:0002684---positive regulation of immune system process
  GOTERM_BP_FAT          GO:0050776---regulation of immune response
  GOTERM_BP_FAT          GO:0050778---positive regulation of immune response
  GOTERM_BP_FAT          GO:0002252---immune effector process
  GOTERM_BP_FAT          GO:0048584---positive regulation of response to stimulus

  Annotation Cluster 2   Enrichment Score: 20.427032466893277
  ---------------------- -----------------------------------------------
  GOTERM_CC_FAT          GO:0009897---external side of plasma membrane
  GOTERM_CC_FAT          GO:0098552---side of membrane
  GOTERM_CC_FAT          GO:0009986---cell surface

  Annotation Cluster 3   Enrichment Score: 15.990954240580606
  ---------------------- -------------------------------------------------------------
  GOTERM_BP_FAT          GO:0006952---defense response
  GOTERM_BP_FAT          GO:0045087---innate immune response
  GOTERM_BP_FAT          GO:0050776---regulation of immune response
  GOTERM_BP_FAT          GO:0050778---positive regulation of immune response
  GOTERM_BP_FAT          GO:0006954---inflammatory response
  GOTERM_BP_FAT          GO:0031349---positive regulation of defense response
  GOTERM_BP_FAT          GO:0031347---regulation of defense response
  GOTERM_BP_FAT          GO:0045089---positive regulation of innate immune response
  GOTERM_BP_FAT          GO:0045088---regulation of innate immune response
  GOTERM_BP_FAT          GO:0002757---immune response‐activating signal transduction

Functional annotation clusters are shown for genes with induction by CaCl~2~ treatment in wild‐type mice that were suppressed in muMT mice. GO term: gene ontology term provided in DAVID (the Database for Annotation, Visualization, and Integrated Discovery) analysis. Only the first 10 terms are shown for simplicity.

###### 

Functional Annotation Clusters of CaCl~2~‐Suppressed Genes With an Influence of B‐Cell Deletion

  Annotation Cluster 1   Enrichment Score: 8.508519489022873
  ---------------------- -------------------------------------
  GOTERM_CC_FAT          GO:0030016---myofibril
  GOTERM_CC_FAT          GO:0043292---contractile fiber
  GOTERM_CC_FAT          GO:0030017---sarcomere
  GOTERM_CC_FAT          GO:0044449---contractile fiber part
  GOTERM_CC_FAT          GO:0031674---I band
  GOTERM_CC_FAT          GO:0030018---Z disc

  Annotation Cluster 2   Enrichment Score: 3.5140614375419363
  ---------------------- --------------------------------------------------
  GOTERM_BP_FAT          GO:0003012---muscle system process
  GOTERM_BP_FAT          GO:0006936---muscle contraction
  GOTERM_BP_FAT          GO:0006941---striated muscle contraction
  GOTERM_BP_FAT          GO:0044057---regulation of system process
  GOTERM_BP_FAT          GO:0090257---regulation of muscle system process
  GOTERM_BP_FAT          GO:0006937---regulation of muscle contraction
  GOTERM_BP_FAT          GO:0008016---regulation of heart contraction
  GOTERM_BP_FAT          GO:0008015---blood circulation
  GOTERM_BP_FAT          GO:0003013---circulatory system process
  GOTERM_BP_FAT          GO:0060047---heart contraction

  Annotation Cluster 3   Enrichment Score: 2.981185764056471
  ---------------------- ---------------------------------------------------
  GOTERM_BP_FAT          GO:0061061---muscle structure development
  GOTERM_BP_FAT          GO:0055002---striated muscle cell development
  GOTERM_BP_FAT          GO:0051146---striated muscle cell differentiation
  GOTERM_BP_FAT          GO:0055001---muscle cell development
  GOTERM_BP_FAT          GO:0060537---muscle tissue development
  GOTERM_BP_FAT          GO:0014706---striated muscle tissue development
  GOTERM_BP_FAT          GO:0042692---muscle cell differentiation
  GOTERM_BP_FAT          GO:0030239---myofibril assembly
  GOTERM_BP_FAT          GO:0031032---actomyosin structure organization
  GOTERM_BP_FAT          GO:0007507---heart development

Functional annotation clusters for genes with suppression by CaCl~2~ treatment in wild‐type mice that were restored in muMT mice. GO term: gene ontology term provided in DAVID (the Database for Annotation, Visualization, and Integrated Discovery) analysis. Only the first 10 terms are shown for simplicity.

Involvement of Immunoglobulins in AAA Pathogenesis {#jah33018-sec-0019}
--------------------------------------------------

Based on our finding that immunoglobulins, the major effector molecules of B cells, were deposited in the aortic walls of Ca‐treated mice, we reasoned that immunoglobulins might be involved in AAA pathogenesis. To test this hypothesis, we administered mouse polyclonal IgG to muMT mice with the CaCl~2~ challenge. IgG with Ca administration caused muMT mice to develop AAA comparable to that observed in WT mice (Figure [5](#jah33018-fig-0005){ref-type="fig"}A). This result indicated that IgG was sufficient for the full development of AAA in muMT mice. We examined the expression and activities of inflammatory and ECM metabolic molecules in muMT AAA tissues (Figure [5](#jah33018-fig-0005){ref-type="fig"}B). CaCl~2~ challenge caused an increase in the expression of Stat3, Lox, and MMP9 and activation of Jnk and Syk. Administration of exogenous IgG caused more significant expression of Jnk, Stat3, Syk, and MMP9; more significant activation of Syk; and less significant expression of Lox.

![Effect of exogenous immunoglobulins on AAA in muMT mice and human AAA tissue in culture. A, Upper, Representative images of abdominal aortas before (Pre) and 6 weeks after CaCl~2~ treatment (Ca) in wild‐type (WT) and mutant B cell‐deficient (muMT) mice, treated with or without exogenous immunoglobulins (Ig). White scale bar 2 mm. Lower, Quantitative analysis of maximal diameters of abdominal aortas. Observation numbers are shown in parentheses at the bottom of the box‐and‐whisker plot. B, Upper, Representative images of immunoblots and zymography show protein expression levels in samples acquired before and 7 days after CaCl~2~ treatment, alone (Ca) or with exogenous immunoglobulins (Ca+Ig) in muMT mice. Lower, Quantitative analyses of the indicated molecules. Columns indicate protein expression levels before treatment (Pre, white), after CaCl~2~ treatment (Ca, dark gray), and after CaCl~2~ with immunoglobulin treatment (Ca+Ig, light gray). Observation numbers are shown in parentheses at the bottom of the box and whisker plots. Values represent fold expression relative to expression in Pre samples. C, Human AAA aortic wall tissue samples were minced and cultured in serum‐free conditions for 48 hours. Basal IL‐6 and MMP9 secretions were measured in culture supernatants. Cultures were then treated without (Control) or with 0.5 mg/mL exogenous human immunoglobulins (Ig) for another 48 hours. Culture supernatants were measured to determine stimulated secretion levels. The ratios of stimulated/basal secretions are shown; Control samples were set to 1. Observation numbers are shown in parentheses at the bottom of the box‐and‐whisker plots. Human immunoglobulins of different lots showed essentially identical results. \**P*\<0.05, \*\**P*\<0.01, \*\*\**P*\<0.001. AAA indicates abdominal aortic aneurysm; MMP9, matrix metalloproteinase‐9; N.S., not significant.](JAH3-7-e007750-g005){#jah33018-fig-0005}

To test whether our findings in mouse AAA models were relevant to human AAA, we examined the effect of immunoglobulins on human AAA tissue in culture. We found that the addition of exogenous immunoglobulin significantly increased the secretions of IL‐6 and MMP9 (Figure [5](#jah33018-fig-0005){ref-type="fig"}C). This result indicated that exogenous immunoglobulins had a proinflammatory effect on human AAA tissues, consistent with our findings in the mouse AAA model. These results suggested that the effects of B cells seemed to be mediated by IgG.

Involvement of Syk in AAA Pathogenesis {#jah33018-sec-0020}
--------------------------------------

To explore a potential therapeutic target for treating AAA, we focused on the role of Syk in AAA pathogenesis because Syk plays a pivotal role in B‐cell activation and in the effector function of immunoglobulins.[19](#jah33018-bib-0019){ref-type="ref"}, [28](#jah33018-bib-0028){ref-type="ref"} Syk is known to modulate various biological processes including apoptosis, cell cycle, inflammatory response, and expression of matrix metalloproteinases.[18](#jah33018-bib-0018){ref-type="ref"}, [29](#jah33018-bib-0029){ref-type="ref"} We examined the effect of B‐cell deletion on these biological processes by examining the expression pattern of genes with these annotations before and 7 days after CaCl~2~ challenge in WT and muMT aortas (Figure [6](#jah33018-fig-0006){ref-type="fig"}, Tables [S1](#jah33018-sup-0001){ref-type="supplementary-material"} through [S4](#jah33018-sup-0001){ref-type="supplementary-material"}). Hierarchical clustering analysis of the gene expression pattern showed that a significant portion of these genes were either induced or suppressed by CaCl~2~ challenge in WT mice, and these changes were ameliorated in muMT mice, indicating that these reportedly Syk‐dependent biological processes were modulated by deletion of B cells.

![Gene expression profile in mouse aorta. Results of the hierarchical clustering analysis of the genes with the indicated annotations are shown by heat map. After log conversion of the signal value, the distance from the median is shown in green, black, and red when lower, intermediate, and higher than those of other samples, respectively, within a given gene.](JAH3-7-e007750-g006){#jah33018-fig-0006}

Next, we treated mice with R788 (fostamatinib), an oral Syk inhibitor,[24](#jah33018-bib-0024){ref-type="ref"} and examined its effect on AAA development after CaCl~2~ challenge. The administration of R788 in drinking water resulted in a significant reduction in the diameter of CaCl~2~‐induced AAA lesions (Figure [7](#jah33018-fig-0007){ref-type="fig"}A). In contrast, CaCl~2~ challenge with vehicle administration induced AAA development comparable to CaCl~2~ alone. These results indicated that Syk was involved in AAA pathogenesis. We examined the inflammatory response 7 days after CaCl~2~ challenge with and without the administration of R788 (Figure [7](#jah33018-fig-0007){ref-type="fig"}B). CaCl~2~ challenge caused a marked increase in IgG deposition. Administration of R788 caused a significant decrease in tissue IgG deposition, whereas it showed no significant effect on the serum level of IgG; this result suggested that IgG deposition was regulated locally in aortic tissue. We also examined Syk, Jnk, Stat3, and Lox with an immunoblot analysis and the MMP9 with gelatin zymography. Mice treated with R788 showed less significant activations of Jnk, Stat3, and Syk, less significant induction of MMP9, and more significant induction of Lox in response to CaCl~2~ challenge. These findings suggested that Syk promoted AAA development by activating the inflammatory response and ECM degradation.

![Effect of Syk inhibitor on murine AAA. A, Upper, Representative images of abdominal aortas, 6 weeks after CaCl~2~ treatment, without (Ca+vehicle) or with R788 administration (Ca+R788). White bar 2 mm. Lower, Quantitative analysis of maximal diameters of abdominal aortas. Observation numbers are shown in parentheses at the bottom of the box‐and‐whisker plot. B, Upper, Representative images of immunoblots and zymography show protein levels and MMP9 activity, respectively, in samples acquired before (Pre) and 7 days after CaCl~2~ treatment, without (Ca+vehicle) or with R788 administration (Ca+R788). Lower*,* Quantitative analyses of the indicated molecules on immunoblots and gelatin zymography (for MMP9). Columns indicate protein expression levels measured before (pre, white columns) or after periaortic application of CaCl~2~, without (dark gray columns) or with R788 treatment (light gray columns). Observation numbers are shown in parentheses at the bottom of the box‐and‐whisker plots. Values indicate fold expression levels relative to expression measured in Pre samples. \**P*\<0.05, \*\**P*\<0.01, \*\*\**P*\<0.001. AAA indicates abdominal aortic aneurysm; MMP9, matrix metalloproteinase‐9; N.S., not significant.](JAH3-7-e007750-g007){#jah33018-fig-0007}

Discussion {#jah33018-sec-0021}
==========

In this study we demonstrated that, in a mouse AAA model induced with a periaortic application of CaCl~2~, B cells promoted the development of AAA through the proinflammatory effect of immunoglobulins. B cell--deficient muMT mice showed reduced AAA expansion, which was associated with blunted inflammatory and tissue destructive activities, compared to WT mice. Administration of exogenous immunoglobulins restored the molecular and morphological phenotypes in muMT to the levels observed in WT AAA mice; moreover, exogenous immunoglobulins stimulated IL‐6 and MMP9 secretions in human AAA tissue cultures. Conversely, inhibition of Syk, a tyrosine kinase essential in B cell--mediated inflammation,[18](#jah33018-bib-0018){ref-type="ref"}, [19](#jah33018-bib-0019){ref-type="ref"}, [20](#jah33018-bib-0020){ref-type="ref"}, [21](#jah33018-bib-0021){ref-type="ref"} ameliorated the inflammatory response and the expansion of AAA in WT mice. These findings indicated that B cells promoted inflammation and an imbalance in ECM metabolism to enhance tissue destruction, and these activities appeared to involve immunoglobulins and Syk.

Several animal models of AAA have been described previously. In WT mice AAA can be induced by exposing the aorta to elastase or CaCl~2~. In *Apoe*‐deficient or *Ldlr*‐deficient hyperlipidemic mice, AAA can be induced with a continuous infusion of angiotensin II. Our finding that B cells were required for the full development of AAA after CaCl~2~ challenge was consistent with previous reports that showed that muMT mice were protected from elastase‐induced AAA[14](#jah33018-bib-0014){ref-type="ref"} and that B cell depletion by anti‐CD20 antibody abrogated AAA development induced by angiotensin II in *Apoe*‐deficient mice.[15](#jah33018-bib-0015){ref-type="ref"} On the other hand, a state of total lymphocyte deficiency attenuated atherosclerosis in *Apoe*‐deficient mice but not angiotensin II--induced AAA[30](#jah33018-bib-0030){ref-type="ref"}; furthermore, muMT mice were not protected from elastase‐induced AAA.[16](#jah33018-bib-0016){ref-type="ref"} A potential explanation for these controversial results could be that T cells participated in AAA pathogenesis by modulating the effect of B cells.[15](#jah33018-bib-0015){ref-type="ref"}, [16](#jah33018-bib-0016){ref-type="ref"} For example, the deletion of all T cells has been reported to abrogate the effect of regulatory T cells in suppressing AAA formation in an angiotensin II--induced model.[31](#jah33018-bib-0031){ref-type="ref"}, [32](#jah33018-bib-0032){ref-type="ref"}, [33](#jah33018-bib-0033){ref-type="ref"} Because no animal model can recapitulate all the aspects of human AAA, further research is required to elucidate the role of B cells in human AAA. In this study we found that administration of exogenous polyclonal immunoglobulins was sufficient to promote IL‐6 and MMP9 secretions in human AAA tissue. Therefore, circulating immunoglobulins may contribute to the maintenance of chronic inflammation in human patients with AAA. B cells residing in AAA tissues may also be important for antigen recognition and continuous production of pathogenic immunoglobulins, including those against fibrinogen, as previously reported, and other endogenous antigens in AAA tissue.[13](#jah33018-bib-0013){ref-type="ref"}, [14](#jah33018-bib-0014){ref-type="ref"} Our finding that immunoglobulins were deposited on AAA tissue and localized to most of adventitial cells suggests that they may activate diverse cell types in AAA tissue.

Most patients with AAA exhibit no symptoms. Therefore, therapeutic interventions should aim to prevent or slow AAA expansion, which may require years of treatment. Our findings and previous reports have indicated that B cells and immunoglobulins have AAA‐promoting effects. However, it would be deleterious to remove whole B cells or immunoglobulins from patients with AAA because of the resulting immunosuppression. Therefore, it is imperative to elucidate how B cells and immunoglobulins exert AAA‐promoting effects. This information will facilitate identification of a therapeutic target that can be modulated, preferably by small therapeutic compounds, to achieve flexibility and adjustability for individual treatments. Of note, in this study we found that Syk was activated in a manner dependent on the presence of B cells and immunoglobulins. Activated Syk was localized in B cells and macrophages, suggesting its involvement in the inflammatory response. Furthermore, R788, a small‐molecule inhibitor of Syk, suppressed the inflammatory response and expansion of AAA. Due to the diverse functions of Syk,[29](#jah33018-bib-0029){ref-type="ref"}, [34](#jah33018-bib-0034){ref-type="ref"}, [35](#jah33018-bib-0035){ref-type="ref"}, [36](#jah33018-bib-0036){ref-type="ref"} the mechanism underlying R788 suppression of AAA expansion may not be limited to its function in B cells. Indeed, we found that Syk is activated not only in B cells but also in other cell types including macrophages. Because the macrophage is an important driver of AAA[37](#jah33018-bib-0037){ref-type="ref"} and Syk is involved in macrophage‐mediated inflammation,[29](#jah33018-bib-0029){ref-type="ref"} activation of macrophage Syk, possibly by the effect of immunoglobulins, may be involved in AAA pathogenesis. Elucidation of such a Syk‐dependent disease mechanism may reveal a new avenue of AAA research. It would be important to examine the effect of a Syk inhibitor on normal aorta and other organs to validate its safety. Although depletion of B cells by anti‐CD20 antibody is another potential option, its effect lasts for months, which may raise a concern for unwanted side effects. The feasibility of Syk inhibition or B‐cell suppression needs to be further tested in a context that more closely mimics a clinical setting.

Other issues that must be addressed, when one is developing pharmacotherapies for AAA, are the relevant time window and duration for applying therapeutic interventions. A potential therapeutic window could be the acute period after introducing a stent‐graft in an EVAR. It is well known that the EVAR procedure causes an acute inflammatory reaction, demonstrated by an increase in circulating C‐reactive protein and MMP9 levels.[38](#jah33018-bib-0038){ref-type="ref"}, [39](#jah33018-bib-0039){ref-type="ref"} That inflammatory response might cause acute degradation in the stent‐graft landing zone, which could compromise long‐term stability.[39](#jah33018-bib-0039){ref-type="ref"} Acute and short‐term suppression of the AAA‐promoting functions of B cells or immunoglobulins, possibly with a Syk inhibitor, may be a feasible intervention to promote long‐term stability after an EVAR. Another potential scenario might be a biomarker‐directed pharmacotherapy, where therapeutic reagents are administered only when the biomarker indicates high disease activity.[40](#jah33018-bib-0040){ref-type="ref"}, [41](#jah33018-bib-0041){ref-type="ref"}

In conclusion, we demonstrated that B cells promoted AAA expansion by enhancing the proinflammatory function of immunoglobulins and that Syk represents a potential therapeutic target in AAA. Further studies are required to understand how B cells are activated and how immunoglobulins and Syk exert proinflammatory functions in the context of AAA. Understanding the B cell--mediated promotion of AAA could lead to the identification of molecular targets for future diagnostic and therapeutic approaches.
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**Table S1.** Expression Analysis of Apoptosis‐Related Genes Expression of apoptosis‐related genes as determined by DNA microarray are shown, which correspond to the top panel of Figure [6](#jah33018-fig-0006){ref-type="fig"}

###### 

Click here for additional data file.
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**Table S2.** Expression Analysis of Cell Cycle--Related Genes Expression of cell cycle--related genes as determined by DNA microarray are shown, which correspond to the second panel of Figure [6](#jah33018-fig-0006){ref-type="fig"}

###### 

Click here for additional data file.
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**Table S3.** Expression Analysis of Inflammatory Response--Related Genes. Expression of inflammatory response--related genes as determined by DNA microarray are shown, which correspond to the third panel of Figure [6](#jah33018-fig-0006){ref-type="fig"}
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Click here for additional data file.
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**Table S4.** Expression Analysis of Matrix Metalloproteinase Genes. Expression of genes for matrix metalloproteinases as determined by DNA microarray are shown, which correspond to the bottom panel of Figure [6](#jah33018-fig-0006){ref-type="fig"}

###### 

Click here for additional data file.
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Click here for additional data file.

We would like to thank Kiyohiro, Nishigata, Nakao, Shiramizu, Nakayama, and Yamamoto for technical assistance.
